Our vision is to sustain health and enhance quality of life by eradicating the pain, suffering and disability caused by arthritis and musculoskeletal, oral and skin conditions. Advances in treatment and prevention across all six research foci provide a formidable means of achieving this vision.
MSK diseases and conditions represent approximately 29 per cent of all the world's chronic illnesses. In Canada, these diseases and conditions account for 10 per cent of the economic burden of illness, second only to cardiovascular disease. According to the "Economic Burden of Illness in Canada, 1998", these diseases and conditions cost tax payers approximately $16 billion/year. With the aging of our population, the incidence of MSK-related diseases and conditions is on the rise, affecting more than half of the Canadian population over the age of 75.
Learn more about us by reading about our:
